[1]
“PROGNOSTIC SIGNIFICANCE OF TRANSCRIPT-TYPE BCR/ABL1 IN CHRONIC MYELOID LEUKEMIA ”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020062, Sep. 2020, doi: 10.4084/mjhid.2020.062.